BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/7/2026 10:15:57 AM | Browse: 5 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 119060
Country China
Category Gastroenterology & Hepatology
Manuscript Type Correspondence
Article Title Letter to the Editor: Precise phenotyping clarifies uric acid-to-high-density lipoprotein cholesterol ratio for cardiovascular risk in metabolic dysfunction-associated steatotic liver disease
Manuscript Source Unsolicited Manuscript
All Author List Peng-Mei Zhou, Chao-Ting Yang, Jian-Feng Bao and Jin-Song Huang
Funding Agency and Grant Number
Corresponding Author Jin-Song Huang, Department of Hepatology, Hangzhou Xixi Hospital Affiliated to Zhejiang Chinese Medical University, No. 2 Hengbu Road, Hangzhou 310023, Zhejiang Province, China. huangjinsongyz@126.com
Key Words Metabolic dysfunction-associated steatotic liver disease; Cardiovascular risk; Uric acid-to-high-density lipoprotein cholesterol ratio; Phenotypic heterogeneity; Risk stratification; Noninvasive assessment
Core Tip The diagnosis of ultrasonography-based metabolic dysfunction-associated steatotic liver disease overlooks hepatic phenotypic heterogeneity and the shared inflammatory metabolic mechanisms of the cardiohepatic axis, potentially confounding the association between uric acid-to-high-density lipoprotein cholesterol ratio (UHR) and cardiovascular disease risk. We argue that precise phenotyping, namely quantification of steatosis using the controlled attenuation parameter or magnetic resonance imaging proton-density fat fraction and staging fibrosis using vibration-controlled transient elastography, is essential to determine whether UHR is an independent predictor of cardiovascular disease risk, thereby clarifying whether UHR is a general biomarker or an indicator of high-risk patients requiring integrated cardiometabolic–hepatic management.
Citation Zhou PM, Yang CT, Bao JF, Huang JS. Letter to the Editor: Precise phenotyping clarifies uric acid-to-high-density lipoprotein cholesterol ratio for cardiovascular risk in metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; In press
Received
2026-01-26 06:53
Peer-Review Started
2026-01-26 06:54
First Decision by Editorial Office Director
2026-02-09 09:47
Return for Revision
2026-02-09 09:47
Revised
2026-02-18 16:55
Publication Fee Transferred
Second Decision by Editor
2026-04-07 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-07 10:15
Articles in Press
2026-04-07 10:15
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com